Life Science Market Report 2025 (Global Edition)

Global Life Science Market Report 2025 Market Size Split by Type (Recombinant Proteins, Cell Lines, Viable Tumor Samples, Tumor Tissue Microarrays, Others), by Application (Drug Discovery and Developm...

Life Science Market Report Description

We have various report editions of Life Science Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.

The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.

Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.

Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.

Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.

Life Science Market Insights Video

Competitive Landscape of the Life Science Market

In the Life Science market's competitive landscape, numerous key competitors are driving innovation and growth. Companies specializing in diagnostics and medical devices focus on advancing diagnostic tools and laboratory equipment, with an increasing emphasis on digital and point-of-care solutions. Demand for early detection and diagnostics, fueled by the growing incidence of chronic diseases, positions these companies for continued growth. Precision medicine and personalized healthcare are rapidly gaining traction, with companies investing in genomics, proteomics, and biomarker discovery to develop targeted therapies.

In March 2024, Cognizant collaborated with NVIDIA to utilize the BioNeMo generative AI platform to enhance drug discovery, targeting increased productivity and lower development costs in the life sciences sector. (Source: https://investors.cognizant.com/news-and-events/news/news-details/2024/Cognizant-to-apply-generative-AI-to-enhance-drug-discovery-for-pharmaceutical-clients-with-NVIDIA-BioNeMo/default.aspx )

Top Companies Market Share in Life Science Industry: (In no particular order of Rank)

• A.M.S. Biotechnology (Europe) Limited
• Bio-Rad Laboratories Inc.
• BPS Bioscience Inc.
• Crown Bioscience Inc.
• Genscript Biotech Corporation
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Life Science Market

Which Region Dominates the Life Science Market in 2024?

According to Cognitive Market Research, North America currently dominates the Life Sciences market, and the region is expected to have significant growth during the projected period. North America is home to some of the largest pharmaceutical and biotechnology companies globally, which dedicate substantial budgets to research and development. The U.S. alone accounted for over 40% of worldwide pharmaceutical R&D expenditures, driving innovation and the creation of new therapies. In 2019, the pharmaceutical sector invested $83 billion in R&D, which, when adjusted for inflation, is roughly ten times what the industry spent annually during the 1980s. Between 2010 and 2019, the number of newly approved drugs surged by 60% compared to the previous decade, reaching a peak of 59 new approvals in 2018. Private investment in drug R&D among member firms of the Pharmaceutical Research and Manufacturers of America (PhRMA), an industry trade association, was approximately $83 billion in 2019, a significant increase from about $5 billion in 1980 and $38 billion in 2000. Additionally, the U.S. government, through organizations like the National Institutes of Health (NIH) and the Food and Drug Administration (FDA), offers substantial funding for biomedical research and innovation, supporting advancements in the life sciences field.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The region has experienced a significant increase in the establishment of biotechnology companies focused on research and development. In 2021, there was a notable surge in biotech startup registrations across the nation, with approximately 1,128 new startups registered—the highest annual figure since 2015. Estimates indicate that the total number of biotechnology startups will reach 6,756 by 2022, with projections suggesting this number will climb to 10,000 by 2025. India's bio-economy has expanded remarkably, growing from US$ 10 billion in 2015 to US$ 130 billion in 2024, and contributing 2.6% to the country's GDP as of 2021. It is expected that India's bio-economy will reach US$ 300 billion by 2030. The COVID-19 vaccination and testing initiatives accounted for nearly a fifth of this sector, totaling US$ 14.56 billion. Furthermore, the Indian biotechnology industry is anticipated to grow to US$ 150 billion by 2025, with the potential to reach between US$ 270 billion and US$ 300 billion by 2030. Countries like China and India are emerging as hubs for biotech innovations, driving the development of new therapies and biopharmaceuticals. The growing emphasis on biologics and biosimilars, which provide targeted treatments for complex diseases, is fueling the expansion of the biotech sector. Additionally, the rising demand for personalized medicine is prompting increased investment in genetic research and development.

The current report Scope analyzes Life Science Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Life Science Market Analysis

According to Cognitive Market Research, the global Life Science market size was estimated at USD XX Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Life Science market with a market size of USD XX million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. In the U.S., the demand for the Life Science market is driven by significant investments in research and development, particularly in biotechnology and pharmaceuticals, as well as the increasing prevalence of chronic diseases that require advanced diagnostic and therapeutic solutions.
• The Canada Life Science market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. In Canada, the demand for the Life Science market is driven by the robust healthcare system that emphasizes research and innovation in drug development and biopharmaceuticals.
• The Mexico Life Science market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD XX million in 2024.

Europe Life Science Market Analysis

According to Cognitive Market Research, the global Life Science market size was estimated at USD XX Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.

• The United Kingdom Life Science market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 7.3% during the forecast period. In the UK, the demand for the Life Science Market is driven by the country’s strong academic and research institutions that contribute to advancements in biotechnology and pharmaceuticals.
• The France Life Science market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD XX million in 2024.
• According to Cognitive Market Research, the German Life Science market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 6.7% during the forecast period. In Germany, the demand for the Life Science Market is driven by the well-established healthcare system, strong support for biopharmaceutical research, and an aging population that requires advanced medical treatments.
• The Italy Life Science market is projected to witness growth at a CAGR of .9% during the forecast period, with a market size of USD XX million in 2024.
• The Russia Life Science market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD XX million in 2024.
• The Spain Life Science market is projected to witness growth at a CAGR of 5.6% during the forecast period with a market size of USD XX million in 2024
• The Luxembourg Life Science market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD XX million in 2024.
• The Portugal Life Science market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD XX million in 2024.
• The Greece Life Science market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD XX million in 2024.
• The Rest of Europe's Life Science market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD XX million in 2024.

Asia Pacific Life Science Market Analysis

According to Cognitive Market Research, the global Life Science market size was estimated at USD XX Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Life Science market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period. In China, the demand for the Life Science market is driven by rapid economic growth, and government initiatives to promote healthcare innovation.
• The Japan Life Science market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD XX million in 2024.
• The India Life Science market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 11.8% during the forecast period. India's significant investments in biotechnology and pharmaceuticals, and an increasing focus on innovative healthcare solutions, driving the market.
• The South Korean Life Science market is projected to witness growth at a CAGR of 9.1% during the forecast period, with a market size of USD XX million in 2024.
• The Australian Life Science market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD XX million in 2024.
• The South East Asia Life Science market is projected to witness growth at a CAGR of 11.0% during the forecast period, with a market size of USD XX million in 2024.
• The Rest of Asia Pacific Life Science market is projected to witness growth at a CAGR of 9.8% during the forecast period, with a market size of USD XX million in 2024.

South America Life Science Market Analysis

According to Cognitive Market Research, the global Life Science market size was estimated at USD XX Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Life Science market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 8.0% during the forecast period. In Brazil, the demand for the Life Science market is driven by the rapid growth of the biotechnology and pharmaceutical sectors, with increasing investments in drug development and production.
• Argentina's Life Science market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period. In Argentina, the demand for the Life Science market is driven by the increasing prevalence of chronic and infectious diseases, coupled with a growing emphasis on improving healthcare access and quality, which propels investments in life sciences.
• Colombia's Life Science market is projected to witness growth at a CAGR of .2% during the forecast period, with a market size of USD XX million in 2024.
• Peru's Life Science market is projected to witness growth at a CAGR of 7.6% during the forecast period, with a market size of USD XX million in 2024.
• Chile's Life Science market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD XX million in 2024.
• The Rest of Latin America's Life Science market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD XX million in 2024.

Middle East Life Science Market Analysis

According to Cognitive Market Research, the global Life Science market size was estimated at USD XX Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031.

• The GCC Countries Life Science market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD XX million in 2024. Life Science sales flourish due to government support for innovation and regulatory reforms aimed at enhancing the healthcare landscape.
• The Egypt Life Science market is projected to witness growth at a CAGR of 8.0% during the forecast period, with a market size of USD XX million in 2024.
• The South Africa Life Science market is projected to witness growth at a CAGR of 8.7% during the forecast period, with a market size of USD XX million in 2024. In South Africa, the demand for the Life Science Market is driven by the growth in biopharmaceutical manufacturing and clinical research, fueled by investments from both domestic and international companies.
• The Turkey Life Science market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD XX million in 2024.
• The Nigeria Life Science market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD XX million in 2024.
• The Rest of the MEA Life Science market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD XX million in 2024.

Life Science Market Analysis

Life Science Market Type Segment Analysis

According to Cognitive Market Research, Recombinant Proteins are likely to dominate the Life Science Market over the forecast period. The development of recombinant DNA technology has revolutionized the production of proteins. Techniques such as genetic engineering, fermentation, and cell culture have made it possible to produce large quantities of recombinant proteins with high purity and specificity. The use of advanced expression systems, including bacterial, yeast, insect, and mammalian cells, has improved the efficiency of recombinant protein production. These systems enable the production of complex proteins that are critical for therapeutic applications.

Cell Lines is the fastest-growing segment in the Life Science Market. The trend toward personalized medicine, which tailors treatment to individual patient profiles, is increasing the need for patient-derived cell lines. These cell lines can be used to evaluate drug responses specific to an individual's genetic makeup, enhancing the development of personalized treatment strategies. Cell lines are used in identifying and validating biomarkers that can predict patient responses to therapies, driving the growth of this segment as the healthcare industry focuses on precision medicine.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Life Science Industry. Request a Free Sample PDF!

Life Science Market Application Segment Analysis

According to Cognitive Market Research, The Drug Discovery and Development Applications segment holds the largest market share. The global burden of chronic diseases such as cancer, diabetes, cardiovascular diseases, and neurological disorders is rising. This trend creates a pressing need for innovative therapies, driving investments in drug discovery and development. As the global population ages, the prevalence of age-related diseases increases, further boosting the demand for novel drug therapies tailored to older adults.

In the Life Science market, the rapidly growing sector is the Biopharmaceutical Production Applications category. There has been a significant increase in investment from both private and public sectors in biopharmaceutical research and development (R&D). Governments and private investors are recognizing the potential of biopharmaceuticals to address unmet medical needs, resulting in more funding for innovative projects. The shift towards personalized medicine is driving the demand for biopharmaceuticals tailored to individual patient needs. This trend necessitates the development of flexible and adaptive biopharmaceutical production processes to accommodate small-batch production and complex biologics.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Life Science End User Segment Analysis

Life Science Market End User Segment Analysis

According to Cognitive Market Research, The Biopharmaceutical Companies segment holds the largest market share. The COVID-19 pandemic highlighted the importance of biopharmaceutical companies in responding to global health challenges. The swift development of vaccines and therapeutics showcased the capacity of these companies to innovate and adapt quickly, reinforcing their critical role in public health. The introduction of adaptive regulatory pathways allows biopharmaceutical companies to bring products to market more quickly. This flexibility encourages innovation and accelerates the development of novel therapies.

In the Life Science market, the rapidly growing sector is the Academic & Research Institutes category. Many governments worldwide are significantly increasing funding for academic research in life sciences, driven by the need to address public health challenges, promote innovation, and enhance national competitiveness. For example, the National Institutes of Health (NIH) in the U.S. has seen its budget grow, allowing it to fund a broad range of biomedical research projects. Academic and research institutions are increasingly collaborating with pharmaceutical and biotechnology companies to advance drug discovery, clinical research, and technology development. These partnerships leverage the expertise and resources of both sectors, resulting in accelerated innovation.

• Biopharmaceutical Companies
• Contract Research Organizations (CROs)
• Academic & Research Institutes
• Others

Life Science Technology Segment Analysis

• Genomics
• Proteomics
• Cell Biology
• Nanotechnology
• Immunotherapy
• Others

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion